Meso Developing Active

生物科技复苏：并购活动和市场表现

评分
0.4
动能
▲ 0.0
文章
13
来源
2

摘要

这篇文章属于这个叙事，如果它讨论了生物科技市场的复苏，重点关注并购活动和整体市场表现。

相关文章

This Biotech Was Quietly Bought Before a $58 Per Share Takeout

Yahoo Finance · 三月 21, 2026
Mixed

This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year

Nasdaq · 三月 20, 2026
Mixed

My Top 3 Drug Stocks for March 2026

Nasdaq · 三月 20, 2026
Bearish

Why biotech is back: IBT portfolio manager’s view

Yahoo Finance · 三月 20, 2026
Mixed

来源

MRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI’s … Yahoo Finance
2 Healthcare Stocks That Could Soar Over the Next 5 … Nasdaq
Moderna Stock is Soaring. Is It Too Late to Buy? Nasdaq
Two Biotech Stocks Hover Near Highs; Natural Gas And Finance … Yahoo Finance
High-Flying Biotech Stock Up 360% Faces $48 Million Trim but … Nasdaq
This Biotech Was Quietly Bought Before a $58 Per Share … Yahoo Finance
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, … Yahoo Finance
This $91 Million Position Signals Conviction in a Biotech Stock … Nasdaq
My Top 3 Drug Stocks for March 2026 Nasdaq
2 Healthcare Stocks to Buy Before They Get Bought Out Nasdaq
Why biotech is back: IBT portfolio manager’s view Yahoo Finance

时间线

最后更新 三月 20, 2026